Overall Technical outlook

Price Summary

On 2025-06-12, Aurobindo Pharma Limited's stock began at 1164.8, peaked at 1180.2, bottomed at 1151.0, and closed -0.82% down at 1155.2, with a volume of 973755 shares.
In the 52-week period, the stock's peak price is 1569.4, and the lowest price recorded is 1051.75.
The projected price range for Aurobindo Pharma Limited is between 1100.0 and 1930.0, with an expected mean price of 1410.5, according to 28 analysts.

Technicals

Support and Resistance: The price of 1155.2 is supported at 1114.5 and faces resistance at 1156.15. This range suggests key levels for AUROPHARMA where the price may stabilize, with 1114.5 acting as a support and 1156.15 as a cap on gains.
AUROPHARMA supportResistance 80211c
Support/Resistance for AUROPHARMA


Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for AUROPHARMA, with no strong trend emerging.
AUROPHARMA aroon 80211c
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The BOLL BANDS is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
AUROPHARMA bbands 80211c
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR maintains a bearish outlook, setting a key resistance level that could limit further gains. This resistance reinforces the bearish sentiment, indicating that the market may face challenges in pushing higher.
AUROPHARMA psar 80211c
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
AUROPHARMA stoch 80211c
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
AUROPHARMA trippleSMA 80211c
Tripple SMA chart for Aurobindo Pharma Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.